These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 7506053

  • 41. Studies on epitopes on low-density lipoprotein modified by 4-hydroxynonenal. Biochemical characterization and determination.
    Chen Q, Esterbauer H, Jürgens G.
    Biochem J; 1992 Nov 15; 288 ( Pt 1)(Pt 1):249-54. PubMed ID: 1280111
    [Abstract] [Full Text] [Related]

  • 42. Glycoxidation and lipid peroxidation of low-density lipoprotein can synergistically enhance atherogenesis.
    Sakata N, Uesugi N, Takebayashi S, Nagai R, Jono T, Horiuchi S, Takeya M, Itabe H, Takano T, Myint T, Taniguchi N.
    Cardiovasc Res; 2001 Feb 01; 49(2):466-75. PubMed ID: 11164857
    [Abstract] [Full Text] [Related]

  • 43. Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein.
    Branch DW, Mitchell MD, Miller E, Palinski W, Witztum JL.
    Lancet; 1994 Mar 12; 343(8898):645-6. PubMed ID: 7509433
    [Abstract] [Full Text] [Related]

  • 44. Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis.
    Cvetkovic JT, Wållberg-Jonsson S, Ahmed E, Rantapää-Dahlqvist S, Lefvert AK.
    Rheumatology (Oxford); 2002 Sep 12; 41(9):988-95. PubMed ID: 12209031
    [Abstract] [Full Text] [Related]

  • 45. Patterns of oxidized epitopes, but not NF-kappa B expression, change during atherogenesis in WHHL rabbits.
    Bräsen JH, Häkkinen T, Malle E, Beisiegel U, Ylä-Herttuala S.
    Atherosclerosis; 2003 Jan 12; 166(1):13-21. PubMed ID: 12482546
    [Abstract] [Full Text] [Related]

  • 46. Peptide mimotopes of malondialdehyde epitopes for clinical applications in cardiovascular disease.
    Amir S, Hartvigsen K, Gonen A, Leibundgut G, Que X, Jensen-Jarolim E, Wagner O, Tsimikas S, Witztum JL, Binder CJ.
    J Lipid Res; 2012 Jul 12; 53(7):1316-26. PubMed ID: 22508944
    [Abstract] [Full Text] [Related]

  • 47. Reduced IgM levels and elevated IgG levels against oxidized low-density lipoproteins in HIV-1 infection.
    Yilmaz A, Jennbacken K, Fogelstrand L.
    BMC Infect Dis; 2014 Mar 17; 14():143. PubMed ID: 24636004
    [Abstract] [Full Text] [Related]

  • 48. A natural antibody to oxidized cardiolipin binds to oxidized low-density lipoprotein, apoptotic cells, and atherosclerotic lesions.
    Tuominen A, Miller YI, Hansen LF, Kesäniemi YA, Witztum JL, Hörkkö S.
    Arterioscler Thromb Vasc Biol; 2006 Sep 17; 26(9):2096-102. PubMed ID: 16794225
    [Abstract] [Full Text] [Related]

  • 49. Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion.
    Torzewski M, Klouche M, Hock J, Messner M, Dorweiler B, Torzewski J, Gabbert HE, Bhakdi S.
    Arterioscler Thromb Vasc Biol; 1998 Mar 17; 18(3):369-78. PubMed ID: 9514405
    [Abstract] [Full Text] [Related]

  • 50. Presence of hypochlorite-modified proteins in human atherosclerotic lesions.
    Hazell LJ, Arnold L, Flowers D, Waeg G, Malle E, Stocker R.
    J Clin Invest; 1996 Mar 15; 97(6):1535-44. PubMed ID: 8617887
    [Abstract] [Full Text] [Related]

  • 51. Autoantibodies to OxLDL are decreased in individuals with borderline hypertension.
    Wu R, de Faire U, Lemne C, Witztum JL, Frostegård J.
    Hypertension; 1999 Jan 15; 33(1):53-9. PubMed ID: 9931081
    [Abstract] [Full Text] [Related]

  • 52. Autoantibodies against modified low density lipoprotein. Nonlipid factor of blood plasma that stimulates foam cell formation.
    Orekhov AN, Tertov VV, Kabakov AE, Adamova IYu, Pokrovsky SN, Smirnov VN.
    Arterioscler Thromb; 1991 Jan 15; 11(2):316-26. PubMed ID: 1998649
    [Abstract] [Full Text] [Related]

  • 53. SYK regulates macrophage MHC-II expression via activation of autophagy in response to oxidized LDL.
    Choi SH, Gonen A, Diehl CJ, Kim J, Almazan F, Witztum JL, Miller YI.
    Autophagy; 2015 Jan 15; 11(5):785-95. PubMed ID: 25946330
    [Abstract] [Full Text] [Related]

  • 54. Anti-modified LDL antibodies and LDL-containing immune complexes in IDDM patients and healthy controls.
    Mironova M, Virella G, Virella-Lowell I, Lopes-Virella MF.
    Clin Immunol Immunopathol; 1997 Oct 15; 85(1):73-82. PubMed ID: 9325072
    [Abstract] [Full Text] [Related]

  • 55. Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM.
    Bellomo G, Maggi E, Poli M, Agosta FG, Bollati P, Finardi G.
    Diabetes; 1995 Jan 15; 44(1):60-6. PubMed ID: 7813815
    [Abstract] [Full Text] [Related]

  • 56. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
    Tsimikas S, Lau HK, Han KR, Shortal B, Miller ER, Segev A, Curtiss LK, Witztum JL, Strauss BH.
    Circulation; 2004 Jun 29; 109(25):3164-70. PubMed ID: 15184281
    [Abstract] [Full Text] [Related]

  • 57. The effects of lipid-lowering therapy on low-density lipoprotein auto-antibodies: relationship with low-density lipoprotein oxidation and plasma total antioxidant status.
    Orem C, Orem A, Uydu HA, Celik S, Erdöl C, Kural BV.
    Coron Artery Dis; 2002 Feb 29; 13(1):65-71. PubMed ID: 11917201
    [Abstract] [Full Text] [Related]

  • 58. Identification of oxidized low density lipoprotein in human renal biopsies.
    Lee HS, Kim YS.
    Kidney Int; 1998 Sep 29; 54(3):848-56. PubMed ID: 9734609
    [Abstract] [Full Text] [Related]

  • 59. Specific recognition of malondialdehyde and malondialdehyde acetaldehyde adducts on oxidized LDL and apoptotic cells by complement anaphylatoxin C3a.
    Veneskoski M, Turunen SP, Kummu O, Nissinen A, Rannikko S, Levonen AL, Hörkkö S.
    Free Radic Biol Med; 2011 Aug 15; 51(4):834-43. PubMed ID: 21683785
    [Abstract] [Full Text] [Related]

  • 60. Carbamyl adducts on low-density lipoprotein induce IgG response in LDLR-/- mice and bind plasma autoantibodies in humans under enhanced carbamylation.
    Kummu O, Turunen SP, Wang C, Lehtimäki J, Veneskoski M, Kastarinen H, Koivula MK, Risteli J, Kesäniemi YA, Hörkkö S.
    Antioxid Redox Signal; 2013 Oct 01; 19(10):1047-62. PubMed ID: 23311771
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.